Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines

被引:18
|
作者
Takeuchi, Yoshinori [1 ]
Fujino, Yasuhito [1 ]
Watanabe, Manabu [2 ]
Nakagawa, Takayuki [3 ]
Ohno, Koichi [1 ]
Sasaki, Nobuo [3 ]
Sugano, Sumio [2 ]
Tsujimoto, Hajime [1 ]
机构
[1] Univ Tokyo, Dept Vet Internal Med, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan
[2] Univ Tokyo, Lab Funct Genom, Dept Med Genome Sci, Grad Sch Frontier Sci,Minato Ku, Tokyo 1088639, Japan
[3] Univ Tokyo, Dept Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan
基金
日本学术振兴会;
关键词
Dog; KIT; Mutation; Stem cell factor; TYROSINE KINASE INHIBITORS; AUTOCRINE LOOP MECHANISM; TANDEM DUPLICATIONS; MUTATIONS; DOGS; SURVIVAL; DOMAIN; IDENTIFICATION; MASTOCYTOSIS; ACTIVATION;
D O I
10.1016/j.vetimm.2010.05.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several studies indicated that KIT mutation could cause ligand-independent activation of c-Kit receptor in canine mast cell tumor (MCT). The objective of this study was to investigate mechanisms of c-Kit receptor activation in various canine MCT cell lines. Four cell lines, HRMC (derived from cutaneous MCT), VIMC1 (visceral MCT), CoMS1 (visceral MCT) and CMMC1 (cutaneous MCT), were cultured in stem cell factor (SCF, a ligand of c-Kit receptor)free medium and subjected to analyses of KIT mutation,c-Kit receptor phosphorylation, SCF expression and the effects of SCF stimulation. In addition, the SCF/c-Kit receptor autocrine mechanism was verified in HRMC cells. HRMC cells expressed wild type c-Kit receptor. Both VIMC1 and CoMS1 cells had the same one amino acid (AA) substitution in the extracellular domain of c-Kit receptor. CMMC1 cells had at least three variants of c-Kit receptor such as one AA deletion in the extracellular domain (variant A), one AA substitution in the extracellular domain as well as an internal tandem duplication in the juxtamembrane domain (variant B), and a nonsense mutation (variant C). Both mature and immature forms of c-Kit receptor were observed and the c-Kit receptors were phosphorylated in all cell lines. While both mature and immature forms of c-Kit receptor were substantially phosphorylated in CMMC1 cells, the immature form was slightly phosphorylated in other cell lines. Phosphorylation of c-Kit receptor in HRMC, VIMC1 and CoMS1 cells were enhanced by SCF stimulation whereas no enhancement was observed in CMMC1 cells. There was no effect of SCF stimulation on proliferation of all the cell lines. SCF protein was detectable in only HRMC cells although mRNA expression of SCF was detected in all the cell lines. A tyrosine kinase inhibitor Dasatinib (internal inhibitor) inhibited c-Kit receptor phosphorylation in HRMC cells whereas anti-canine SCF antibody (external inhibitor) had no inhibitory effect. Thus there could be no external SCF/c-Kit receptor autocrine mechanism whereas there could be an internal autocrine mechanism within HRMC cells. The results indicated that consistent c-Kit receptor phosphorylation could be caused by the stimulation with autocrine SCF in HRMC cells while it could be caused by functional mutations of KIT in VIMC1, CoMS1 and CMMC1 cells. As the four canine MCT cell lines had various aberrations associated with c-Kit receptor phosphorylation, KIT mutation and SCF expression, such molecular biological diversity might reflect the different biological behavior in canine MCT. (c) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:208 / 216
页数:9
相关论文
共 50 条
  • [1] KIT RECEPTOR EXPRESSION IN CANINE CUTANEOUS MAST CELL TUMORS (CMCTs) WITHOUT C-KIT MUTATION
    Vucicevic, Ivana
    Marinkovic, Darko
    Kukolj, Vladimir
    Vucicevic, Milos
    Mirilovic, Milorad
    Nesic, Sladan
    Aleksic-Kovacevic, Sanja
    ACTA VETERINARIA-BEOGRAD, 2016, 66 (02): : 222 - 233
  • [2] Reovirus changes the expression of anti-apoptotic and proapoptotic proteins with the c-kit downregulation in canine mast cell tumor cell lines
    Hwang, Chung Chew
    Igase, Masaya
    Okuda, Masaru
    Coffey, Matt
    Noguchi, Shunsuke
    Mizuno, Takuya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 517 (02) : 233 - 237
  • [3] Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours
    London, CA
    Kisseberth, WC
    Galli, SJ
    Geissler, EN
    Helfand, SC
    JOURNAL OF COMPARATIVE PATHOLOGY, 1996, 115 (04) : 399 - 414
  • [4] Peripheral blood expression of c-kit proto-oncogene in canine mast cell tumor
    Xavier, J. G.
    Kleeb, S. R.
    Canavez, F. C.
    Sousa-Canavez, J. M.
    HISTOPATHOLOGY, 2010, 57 : 263 - 264
  • [5] Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy
    Kobayashi, Masato
    Sugisaki, Osamu
    Ishii, Noriko
    Yamada, Osamu
    Ito, Keita
    Kuroki, Shiori
    Sasaki, Yu
    Ono, Kenichiro
    Washizu, Tsukimi
    Bonkobara, Makoto
    VETERINARY JOURNAL, 2012, 193 (01): : 264 - 267
  • [6] Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors
    Webster, JD
    Kiupel, M
    Yuzbasiyan-Gurkan, V
    BMC CANCER, 2006, 6 (1)
  • [7] Evaluation of an intron deletion in the c-kit gene of canine mast cell tumors
    Reguera, MJ
    Ferrer, L
    Rabanal, RM
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2002, 63 (09) : 1257 - 1261
  • [8] Mutations in C-KIT exon 11 in canine cutaneous mast cell tumors
    Rafael T Neto
    Didir Q Cagnini
    Renée L Amorim
    BMC Proceedings, 7 (Suppl 2)
  • [9] The role of c-KIT in tumorigenesis:: Evaluation in canine cutaneous mast cell tumors
    Webster, Joshua D.
    Yuzbasiyan-Gurkan, Vilma
    Kaneene, John B.
    Miller, RoseAnn
    Resau, James H.
    Kiupel, Matti
    NEOPLASIA, 2006, 8 (02): : 104 - 111
  • [10] Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors
    Joshua D Webster
    Matti Kiupel
    Vilma Yuzbasiyan-Gurkan
    BMC Cancer, 6